Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.
Andrea RomigiMichelangelo MaestriCarmine NicolettaGiuseppe VitraniMarco CaccamoGabriele SicilianoEnrica BonanniDiego CentonzeAlessandro SanduzziPublished in: Current neurology and neuroscience reports (2019)
Although DM2 has been poorly evaluated, the most relevant sleep disorders are sleep-disordered breathing (SDB) (37.5-66.7%) and restless legs syndrome (RLS) (50-60%). Excessive daytime somnolence (EDS) is not consistent with SDB, and a large percentage of patients with sleep complaints (58-69%) report pain. In addition, respiratory dysfunctions are reported in 6 to 15% of DM2 patients, albeit few data are available regarding pulmonary restriction, hypoventilation, and non-invasive ventilation (NIV). SDB, RLS, and pain may contribute to sleep fragmentation and EDS in DM2. In addition, few studies report hypoventilation and pulmonary restriction, although there are no studies at all on NIV, except for limited clinical experiences. These findings suggest performing a careful pulmonary examination and NIV when required. Furthermore, sleep studies and respiratory evaluation should be recommended if OSA or respiratory muscle dysfunctions are suspected. A large polysomnographic study should be performed to clarify the link between sleep disorders, pain, and sleep disruption in DM2.
Keyphrases
- sleep quality
- physical activity
- chronic pain
- pulmonary hypertension
- pain management
- obstructive sleep apnea
- end stage renal disease
- mental health
- ejection fraction
- spinal cord
- spinal cord injury
- peritoneal dialysis
- intensive care unit
- case control
- electronic health record
- early onset
- adipose tissue
- duchenne muscular dystrophy